Dermata Therapeutics, Inc. (DRMA)

Dermata Therapeutics reports Q1 2026 earnings with a narrower loss of $1.85M, beating estimates. The company pivots from pharma to DTC skincare with its new Tome brand launch.

The Roundhill Memory ETF (CBOE:DRAM) opened for trading on April 2, 2026 as the first U.S.-listed ETF dedicated purely to memory chip manufacturers, arriving as memory contract prices were already accelerating. DRAM has climbed 98% since inception, including a roughly 30% gain in the past week, ...

Looking to buy Dermata Therapeutics Stock? Get the latest DRMA quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.

Shareholders of Dermapharm Holding SE ( ETR:DMP ) will be pleased this week, given that the stock price is up 12% to...

DRMA showed a 1.64% gain while close peers were mixed: BDRX up 3.02%, SLXN up 15.8%, ENTO down 5.68%, GLTO down 0.21%, TOVX down 3.77%. This mixed tape and scanner data with SLXN down 1.82% and TOVX up 1.39% point to stock-specific trading rather than a coordinated sector move. ... Earnings updates …